Literature DB >> 15713646

Interferon-inducible protein 9 (CXCL11)-induced cell motility in keratinocytes requires calcium flux-dependent activation of mu-calpain.

Latha Satish1, Harry C Blair, Angela Glading, Alan Wells.   

Abstract

Keratinocyte migration is critical to reepithelialization during wound repair. The motility response is promoted by growth factors, cytokines, and cytokines produced in the wound bed, including those that activate the epidermal growth factor (EGF) receptor. The Alu-Leu-Arg-negative CXC chemokine interferon-inducible protein 9 (IP-9; also known as CXCL11, I-TAC, beta-R1, and H-174) is produced by keratinocytes in response to injury. As keratinocytes also express the receptor, CXCR3, this prompted us to examine the role and molecular mechanism by which IP-9 regulates keratinocyte motility. Unexpectedly, as CXCR3 liganding blocks growth factor-induced motility in fibroblasts, IP-9 alone promoted motility in undifferentiated keratinocytes (37 +/- 6% of the level of the highly motogenic EGF) as determined in a two-dimensional in vitro wound healing assay. IP-9 even enhanced EGF-induced motility in undifferentiated keratinocytes (116 +/- 5%; P < 0.05 compared to EGF alone), suggesting two separate mechanisms of action. IP-9-increased motility and -decreased adhesiveness required the intracellular protease calpain. The increases in both motility and calpain activity by IP-9 were blocked by pharmacological and molecular inhibition of phospholipase C-beta3 and chelation of calcium, which prevented an intracellular calcium flux. Molecular downregulation or RNA interference-mediated depletion of mu-calpain (calpain 1) but not M-calpain (calpain 2) blocked IP-9-induced calpain activation and motility. In accord with elimination of IP-9-induced de-adhesion, RNA interference-mediated depletion of calpain 1 but not calpain 2 prevented cleavage of the focal adhesion component focal adhesion kinase and disassembly of vinculin aggregates. In comparison, EGF-induced motility of the same undifferentiated keratinocytes requires the previously described extracellular signal-regulated kinase to the M-calpain pathway. These data demonstrate that while both EGF- and IP-9-induced motility in keratinocytes requires calpain activity, the isoform of calpain triggered depends on the nature of the receptor for the particular ligand. Interestingly, physiological nonapoptotic calcium fluxes were capable of activating mu-calpain, implying that the calcium requirement of mu-calpain for activation is attained during cell signaling. This is also the first demonstration of differential activation of the two ubiquitous calpain isoforms in the same cell by different signals.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15713646      PMCID: PMC549356          DOI: 10.1128/MCB.25.5.1922-1941.2005

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  62 in total

Review 1.  Cutaneous wound healing.

Authors:  A J Singer; R A Clark
Journal:  N Engl J Med       Date:  1999-09-02       Impact factor: 91.245

2.  Calpastatin subdomains A and C are activators of calpain.

Authors:  Peter Tompa; Zoltan Mucsi; Gyorgy Orosz; Peter Friedrich
Journal:  J Biol Chem       Date:  2002-01-23       Impact factor: 5.157

3.  Casein zymography of calpains using a 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid-imidazole buffer.

Authors:  Dorothy E Croall; Katherin Moffett; Harold Hatch
Journal:  Anal Biochem       Date:  2002-05-01       Impact factor: 3.365

4.  Subcellular localization and in vivo subunit interactions of ubiquitous mu-calpain.

Authors:  Shirley Gil-Parrado; Oliver Popp; Tobias A Knoch; Stefan Zahler; Felix Bestvater; Marcel Felgenträger; Andreas Holloschi; Amaury Fernández-Montalván; Ennes A Auerswald; Hans Fritz; Pablo Fuentes-Prior; Werner Machleidt; Eberhard Spiess
Journal:  J Biol Chem       Date:  2003-02-18       Impact factor: 5.157

5.  Activation of m-calpain (calpain II) by epidermal growth factor is limited by protein kinase A phosphorylation of m-calpain.

Authors:  Hidenori Shiraha; Angela Glading; Jeffrey Chou; Zongchao Jia; Alan Wells
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

6.  Epidermal growth factor induces acute matrix contraction and subsequent calpain-modulated relaxation.

Authors:  Fred D Allen; Clara F Asnes; Philip Chang; Elliot L Elson; Douglas A Lauffenburger; Alan Wells
Journal:  Wound Repair Regen       Date:  2002 Jan-Feb       Impact factor: 3.617

7.  Lysophosphatidylcholine inhibits endothelial cell migration by increasing intracellular calcium and activating calpain.

Authors:  Pinaki Chaudhuri; Scott M Colles; Derek S Damron; Linda M Graham
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-02-01       Impact factor: 8.311

8.  Calpain regulates neutrophil chemotaxis.

Authors:  M A Lokuta; P A Nuzzi; A Huttenlocher
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-20       Impact factor: 11.205

9.  Glutamate substitutions at a PKA consensus site are consistent with inactivation of calpain by phosphorylation.

Authors:  Scott D Smith; Zongchao Jia; Kassidy K Huynh; Alan Wells; John S Elce
Journal:  FEBS Lett       Date:  2003-05-08       Impact factor: 4.124

10.  An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4.

Authors:  Laura Lasagni; Michela Francalanci; Francesco Annunziato; Elena Lazzeri; Stefano Giannini; Lorenzo Cosmi; Costanza Sagrinati; Benedetta Mazzinghi; Claudio Orlando; Enrico Maggi; Fabio Marra; Sergio Romagnani; Mario Serio; Paola Romagnani
Journal:  J Exp Med       Date:  2003-06-02       Impact factor: 14.307

View more
  34 in total

1.  m-Calpain activation is regulated by its membrane localization and by its binding to phosphatidylinositol 4,5-bisphosphate.

Authors:  Ludovic Leloup; Hanshuang Shao; Yong Ho Bae; Bridget Deasy; Donna Stolz; Partha Roy; Alan Wells
Journal:  J Biol Chem       Date:  2010-08-20       Impact factor: 5.157

Review 2.  Chemokines in Wound Healing and as Potential Therapeutic Targets for Reducing Cutaneous Scarring.

Authors:  Peter Adam Rees; Nicholas Stuart Greaves; Mohamed Baguneid; Ardeshir Bayat
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-11-01       Impact factor: 4.730

Review 3.  Chemokine Involvement in Fetal and Adult Wound Healing.

Authors:  Swathi Balaji; Carey L Watson; Rajeev Ranjan; Alice King; Paul L Bollyky; Sundeep G Keswani
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-11-01       Impact factor: 4.730

Review 4.  CXCR3 in carcinoma progression.

Authors:  Bo Ma; Ahmad Khazali; Alan Wells
Journal:  Histol Histopathol       Date:  2015-02-09       Impact factor: 2.303

5.  Spatial localization of m-calpain to the plasma membrane by phosphoinositide biphosphate binding during epidermal growth factor receptor-mediated activation.

Authors:  Hanshuang Shao; Jeff Chou; Catherine J Baty; Nancy A Burke; Simon C Watkins; Donna Beer Stolz; Alan Wells
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

Review 6.  The Roles of Growth Factors in Keratinocyte Migration.

Authors:  Mark A Seeger; Amy S Paller
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-04-01       Impact factor: 4.730

Review 7.  The Beginning of the End: CXCR3 Signaling in Late-Stage Wound Healing.

Authors:  Arthur C Huen; Alan Wells
Journal:  Adv Wound Care (New Rochelle)       Date:  2012-12       Impact factor: 4.730

8.  ELR-negative CXC chemokine CXCL11 (IP-9/I-TAC) facilitates dermal and epidermal maturation during wound repair.

Authors:  Cecelia C Yates; Diana Whaley; Amy Y-Chen; Priya Kulesekaran; Patricia A Hebda; Alan Wells
Journal:  Am J Pathol       Date:  2008-07-31       Impact factor: 4.307

9.  IP-10 blocks vascular endothelial growth factor-induced endothelial cell motility and tube formation via inhibition of calpain.

Authors:  Richard J Bodnar; Cecelia C Yates; Alan Wells
Journal:  Circ Res       Date:  2006-02-16       Impact factor: 17.367

10.  Interferon-gamma reduces cell surface expression of annexin 2 and suppresses the invasive capacity of prostate cancer cells.

Authors:  Claire Hastie; John R Masters; Stephen E Moss; Soren Naaby-Hansen
Journal:  J Biol Chem       Date:  2008-01-22       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.